Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Riveline

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Diabetes & Metabolism|September 18, 2012
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFEP-Y Benhamou, B Catargi, B Delenne, et al.
Diabetes & Metabolism|November 17, 2009
Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patientsS Franc, D Dardari, B Boucherie, et al.
Diabetes & Metabolism|January 7, 2004
Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experienceH Gin, E Renard, V Melki, et al.
Diabetes & Metabolism|November 30, 2019
Determinants of aspirin resistance in patients with type 2 diabetesE Paven, J-G Dillinger, C Bal Dit Sollier, et al.
Diabetes & Metabolism|March 23, 2010
Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapyJ-P Riveline, S Franc, M Biedzinski, et al.
Diabetes & Metabolism|February 22, 2008
Insulin-pump use in everyday practice: data from an exhaustive regional registry in FranceJ-P Riveline, F-X Jollois, N Messaoudi, et al.
Diabetes & Metabolism|August 12, 2015
Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statementM Joubert, S Baillot-Rudoni, B Catargi, et al.
Diabetes & Metabolism|November 18, 2006
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative studyL Dufaitre-Patouraux, J P Riveline, E Renard, et al.
Diabetes & Metabolism|November 23, 2021
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 studyJ P Riveline, B Vergés, B Detournay, et al.
Diabetes & Metabolism|November 28, 2017
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statementS Borot, P Y Benhamou, C Atlan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Diabetes & Metabolism|September 18, 2012
Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFEP-Y Benhamou, B Catargi, B Delenne, et al.
Diabetes & Metabolism|November 17, 2009
Real-life application and validation of flexible intensive insulin-therapy algorithms in type 1 diabetes patientsS Franc, D Dardari, B Boucherie, et al.
Diabetes & Metabolism|January 7, 2004
Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experienceH Gin, E Renard, V Melki, et al.
Diabetes & Metabolism|November 30, 2019
Determinants of aspirin resistance in patients with type 2 diabetesE Paven, J-G Dillinger, C Bal Dit Sollier, et al.
Diabetes & Metabolism|March 23, 2010
Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapyJ-P Riveline, S Franc, M Biedzinski, et al.
Diabetes & Metabolism|February 22, 2008
Insulin-pump use in everyday practice: data from an exhaustive regional registry in FranceJ-P Riveline, F-X Jollois, N Messaoudi, et al.
Diabetes & Metabolism|August 12, 2015
Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statementM Joubert, S Baillot-Rudoni, B Catargi, et al.
Diabetes & Metabolism|November 18, 2006
Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative studyL Dufaitre-Patouraux, J P Riveline, E Renard, et al.
Diabetes & Metabolism|November 23, 2021
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 studyJ P Riveline, B Vergés, B Detournay, et al.
Diabetes & Metabolism|November 28, 2017
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statementS Borot, P Y Benhamou, C Atlan, et al.
Pageof 4